Group
Brands
- PharmaNutra
  - SiderAL
  - SiderAL Forte
  - SiderAL Folico
  - Cardio SiderAL
  - Cetilar Crema
  - ApportAL
  - UltraMag
  - Gestalys DHA
  - Novomega
  - Bonecal
  - DiKappa2
- Junia Pharma
- Alesco
Investor Relations
- INVESTOR
- PRESS
  - Press releases
  - Press review
Governance
Media
- News
- Social commitment
Careers
- Work with us
- Job offers

Group
Brands
- PharmaNutra
  - SiderAL
  - SiderAL Forte
  - SiderAL Folico
  - Cardio SiderAL
  - Cetilar Crema
  - ApportAL
  - UltraMag
  - Gestalys DHA
  - Novomega
  - Bonecal
  - DiKappa2
- Junia Pharma
- Alesco
Investor Relations
- INVESTOR
- PRESS
  - Press releases
  - Press review
Governance
Media
- News
- Social commitment
Careers
- Work with us
- Job offers

it
en

12 November 2019 |

PHARMANUTRA S.P.A. OBTAINS PATENT FOR A NEW COMPOSITION USED FOR TREATING CARDIOVASCULAR DISEASES

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info

info@pharmanutra.it

Candidature

recruiting@pharmanutra.it

Commerciale

commerciale@pharmanutra.it

Investor relations

investorrelation@pharmanutra.it

Distribution

internationaldept@pharmanutra.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter

Privacy policy Cookie policy General conditions Code of ethics 231 Model

© 2020 PharmaNutra SpA - All rights reserved